University Hospital Schleswig-Holstein

Futó vizsgálatok

• Még nem toboroz

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

  NCT07291102· 3. fázis· Nationwide Children's Hospital· Forrás

• Még nem toboroz

  Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR

  NCT07696182· Abbott Medical Devices· Forrás

• Toboroz

  Cevostamab in Combination With Pomalidomide and Dexamethasone After BCMA- Targeting CAR T-Cell Therapy in Participants With Previously Treated Multiple Myeloma

  NCT07825064· 2. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Még nem toboroz

  A study to Evaluate the Efficacy and Safety of ENV-294 in Adult Participants with Moderate-to-Severe Atopic Dermatitis

  2026-526184-38-00· 2. fázis· Enveda Therapeutics Inc.· Forrás

• Toboroz

  Efanesoctocog alfa treatment in patients with congenital hemophilia A suffering from inflammation of joint lining

  2025-523896-44-00· 3. fázis· GWT-Tud GmbH· Forrás

• Toboroz

  Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)

  2026-525489-23-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  Observational Study With CICR-NAM as a Food for Special Medicinal Purposes in Post-COVID Syndrome (PCS)

  NCT07798570· University Hospital Schleswig-Holstein· Forrás

• Toboroz

  A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC

  NCT07807163· 2. fázis· Bicara Therapeutics· Forrás

• Még nem toboroz

  AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

  2025-522190-11-01· 3. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Még nem toboroz

  Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.

  2026-526419-13-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  NCT07761117· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· AstraZeneca· Forrás

• Toboroz

  FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS

  NCT07674667· 1/2. fázis· Trace Neuroscience, Inc.· Forrás

• Toboroz

  A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic markers in patients with resected pancreatic carcinoma

  NCT05314998· 3. fázis· Universitaetsklinikum Heidelberg AöR· Forrás

• Toboroz

  BGB-43395 in Combination with Letrozole versus CDK4/6i with Letrozole for Patients with Previously Untreated Advanced or Metastatic HR+/HER2- Breast Cancer

  NCT07492641· 3. fázis· BeOne Medicines I GmbH· Forrás

• Még nem toboroz

  Augmented Reality Aided Remote Access and Technical Support for Complex Ablation Procedures

  NCT07777042· University of Luebeck· Forrás

• Még nem toboroz

  Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed, Moderate-to-severe Crohn's Disease

  NCT07659353· 4. fázis· University Hospital Schleswig-Holstein· Forrás

• Toboroz

  A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis

  2025-523127-21-00· 1. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Toboroz

  The RAPID-Elapse study: Can the drug bupropion improve fatigue symptoms in patients with long COVID?

  2025-524443-12-00· 2. fázis· Goethe University Frankfurt· Forrás

• Toboroz

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

  NCT07516951· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.

  NCT07672236· 3. fázis· OncoZenge AB· Forrás

• Még nem toboroz

  Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?

  2026-525513-31-00· 3. fázis· Norges Teknisk-Naturvitenskapelige Universitet NTNU· Forrás

• Még nem toboroz

  GMMG-HD11/DSMM XXI/64007957MMY3010

  NCT07671287· 3. fázis· University of Heidelberg Medical Center· Forrás

• Toboroz

  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT07690371· 3. fázis· Nektar Therapeutics· Forrás

• Toboroz

  Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

  NCT07555938· 3. fázis· Hoffmann-La Roche· Forrás

• Meghívásos bevonás

  Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

  NCT07652294· 2. fázis· Spyre Therapeutics, Inc.· Forrás

• Még nem toboroz

  Valvosoft Outcomes Registry for Real-World Evidence

  NCT07520591· Cardiawave SA· Forrás

• Toboroz

  Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year

  2025-521590-13-00· 3. fázis· Janssen Cilag International· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

  NCT07571174· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· 3. fázis· Novo Nordisk A/S· Forrás

• Még nem toboroz

  Impact of Diet on the Microbiome-Immune-Brain Axis in Parkinson's Disease

  NCT06463769· University of Kiel· Forrás

• Fut, nem toboroz

  A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

  2025-522440-41-00· 2. fázis· Bluefin Biomedicine Inc.· Forrás

• Toboroz

  Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support

  NCT07655479· University Hospital of Cologne· Forrás

• Toboroz

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria

  2025-522878-36-00· 3. fázis· Celldex Therapeutics Inc.· Forrás

• Toboroz

  Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants

  2025-521762-99-00· 3. fázis· University Medical Center Hamburg-Eppendorf· Forrás

• Fut, nem toboroz

  Evaluation of efficacy and safety of early in hospital initiation of inclisiran treatment in patients with acute coronary syndromes

  2025-521670-34-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

  NCT07449702· 2. fázis· Oruka Therapeutics, Inc.· Forrás

• Toboroz

  A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With Acute Ischemic Stroke

  NCT07367100· Neuravi Limited· Forrás

• Még nem toboroz

  Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -

  NCT07386912· Research Center Borstel· Forrás

• Fut, nem toboroz

  Phase IIB Study of PHENOGENE-1A (Cromolyn) as an Adjuvant Therapy in Mild to Moderate ALS

  2025-520688-42-00· 2. fázis· Phenonet Inc.· Forrás

• Még nem toboroz

  IZABRIGHT-Lung01: Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI Therapy

  2025-521908-22-00· 2/3. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás

• Toboroz

  A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

  NCT07384975· 2. fázis· Navigator Medicines, Inc.· Forrás

• Fut, nem toboroz

  A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

  NCT07277660· 2. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residual disease.

  2024-512503-39-00· 4. fázis· Medizinische Hochschule Hannover· Forrás

Showing 50 of 263.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok19 toboroz
• Crohn-betegség14 toboroz
• Akut limfoid leukémia (ALL)10 toboroz
• Atópiás dermatitisz (ekcéma)9 toboroz
• Colitis ulcerosa7 toboroz
• Mielóma multiplex7 toboroz
• Szívelégtelenség7 toboroz
• Tüdőrák7 toboroz
• Akut mieloid leukémia (AML)6 toboroz
• Krónikus limfoid leukémia (CLL)6 toboroz
• Aortic stenosis5 toboroz
• Melanóma5 toboroz
• Pikkelysömör5 toboroz
• Hidradenitis suppurativa4 toboroz
• Köpenysejtes limfóma4 toboroz
• Pitvarfibrilláció4 toboroz
• Stroke (szélütés)4 toboroz
• Áttétes emlőrák3 toboroz
• Bronchiectasis3 toboroz
• Fej-nyaki daganatok3 toboroz
• Koszorúér-betegség3 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)3 toboroz
• Mielodiszplasztikus szindróma (MDS)3 toboroz
• Parkinson-kór3 toboroz
• Amiotrófiás laterálszklerózis (ALS)2 toboroz
• Chronic spontaneous urticaria2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Follikuláris limfóma2 toboroz
• Hólyagrák2 toboroz
• Long COVID és ME/CFS2 toboroz
• Lupus (SLE)2 toboroz
• Magas vérnyomás2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Prosztatarák2 toboroz
• Rheumatoid arthritis2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Vitiligo2 toboroz
• Alopecia areata1 toboroz
• Alzheimer-kór1 toboroz
• Amiloidózis1 toboroz
• Asztma1 toboroz
• Brain metastases1 toboroz
• Cisztás fibrózis1 toboroz
• Csontritkulás1 toboroz
• Deep vein thrombosis and pulmonary embolism1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Elhízás1 toboroz
• Essential tremor1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hemofília1 toboroz
• Huntington-kór1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• Immune thrombocytopenia (ITP)1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Krónikus vesebetegség1 toboroz
• Lichen planus1 toboroz
• Liver cirrhosis1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Mild cognitive impairment1 toboroz
• Neuroblasztóma1 toboroz
• Petefészekrák1 toboroz
• Policisztás vesebetegség1 toboroz
• Sarcoidosis1 toboroz
• Szarkóma1 toboroz
• Tripla negatív emlőrák1 toboroz
• Tuberkulózis1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Toboroz

  Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  NCT07214779· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned After or did not respond to Cancer Immunotherapy (ABBIL1TY MELANOMA-07)

  NCT06984328· 2. fázis· Genmab A/S· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participants With Ulcerative Colitis

  NCT06975722· 2. fázis· Sanofi· Forrás

• Lezárult

  A multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer (NeoTRACE)

  2024-517561-16-00· 2. fázis· AIO-Studien gGmbH· Forrás

• Fut, nem toboroz

  A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT06291220· 1. fázis· AbbVie· Forrás

• Lezárult

  Long-Term Extension Study (AtDvance) to Evaluate the Safety and Efficacy of GSK1070806 in Participants with Moderate to Severe Atopic Dermatitis.

  NCT06447506· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

  NCT06433219· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511363-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Lezárult

  How Metabolism Affects Weight Loss and Gain

  NCT06860776· University Hospital Schleswig-Holstein· Forrás

• Fut, nem toboroz

  Phase IIa Study Evaluating AZD7798 in Crohn's Disease

  NCT06450197· 2. fázis· AstraZeneca· Forrás

• Lezárult

  Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis

  2023-508679-34-00· 2. fázis· Anaptysbio Inc.· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06586112· 3. fázis· Alumis Inc· Forrás

• Lezárult

  A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás

• Lezárult

  Randomized adaptive assessment of post COVID syndrome treatments (RAPID) Reducing Inflammatory Activity in Patients with post COVID Syndrome (REVIVE)

  2024-511628-16-00· 2. fázis· Goethe University Frankfurt· Forrás

• Lezárult

  A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

  NCT06431763· 4. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A clinical study comparing different doses of a potential new medicine with an inactive medicine for patients with moderate to severe psoriasis

  2023-508992-35-00· 2. fázis· Janssen Cilag International· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants with Moderate to Severe Ulcerative Colitis

  2023-506655-19-00· 2. fázis· Genentech Inc.· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

  NCT06407934· 3. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Erasca, Inc.· Forrás

• Lezárult

  Kinetics and Metabolism of Nicotinamide Provided as a Dietary Supplementation

  NCT07156929· University Hospital Schleswig-Holstein· Forrás

• Lezárult

  A Phase 2b, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Dose Finding study to evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GSK1070806 SC injection in Adult Participants with Moderate to Severe Atopic Dermatitis

  NCT05999799· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  Regorafenib-pembrolizumab vs. TACE/TARE in intermediate-stage HCC beyond up-to-7.

  NCT04777851· 3. fázis· Translational Research In Oncology· Forrás

• Fut, nem toboroz

  A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

  NCT06257875· 2. fázis· AbbVie· Forrás

• Lezárult

  A proof of concept and dose-finding study of XXB750 in patients with heart failure

  2023-504678-39-00· 2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 β/γ, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

  2023-506092-10-00· 2. fázis· Ascendis Pharma Oncology Division A/S· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

  NCT06224348· 3. fázis· Sanofi· Forrás

• Leállították

  Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

  NCT05999968· 1. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· 3. fázis· Boehringer Ingelheim· Forrás

• Leállították

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás

• Lezárult

  Safety, tolerability, and efficacy of ACOU085 for prevention of hearing loss in testicular cancer patients receiving cisplatin

  NCT06521190· 2. fázis· Acousia Therapeutics GmbH· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

  NCT06130566· 3. fázis· Sanofi· Forrás

• Leállították

  The RECOVER IV Trial

  NCT05506449· Abiomed Inc.· Forrás

• Lezárult

  A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

  2023-505558-16-00· 3. fázis· Almirall S.A.· Forrás

• Fut, nem toboroz

  A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

  NCT06045806· 3. fázis· Celgene· Forrás

• Lezárult

  A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06049017· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

  NCT05923099· 2. fázis· LEO Pharma· Forrás

• Leállították

  Metabolic Phenotyping for Personalized Obesity Therapy

  NCT06874270· University Hospital Schleswig-Holstein· Forrás

• Lezárult

  Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

  NCT05936567· 2. fázis· Incyte Corporation· Forrás

• Lezárult

  Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis

  NCT05672199· 2. fázis· Amgen Inc.· Forrás

• Lezárult

  Phase 2 Study of Preoperative Gemcitabine Plus Cisplatin with Durvalumab (MEDI4736) and Tremelimumab in intrahepatic cholangiocarcinoma (NeoTreme)

  2024-515660-31-00· 2. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Lezárult

  Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

  NCT05804032· 3. fázis· University of Heidelberg Medical Center· Forrás

• Lezárult

  Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

  NCT05499832· 3. fázis· Insel Gruppe AG, University Hospital Bern· Forrás

• Lezárult

  Allogeneic stem cell transplantation vs. conventional therapy as salvage therapy for relapsed / progressed patients with multiple myeloma after first-line therapy (AlloRelapseMMStudy)

  NCT05675319· 3. fázis· University Medical Center Hamburg-Eppendorf· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Visszavonták

  Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1

  NCT05219864· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  Cardiac safety of treosulfan chemotherapy prior to stem cell transplantation in patients with leukemia.

  2024-517377-24-00· 1. fázis· Medac Gesellschaft fuer klinische Spezialpraeparate mbH· Forrás

• Lezárult

  Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN High Risk, Cisplatin-ineligible Participants (XRAY VISION)

  2023-508528-36-00· 3. fázis· Merck Healthcare KGaA· Forrás

• Lezárult

  Study of Nemvaleukin Alfa in Combination with Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients with Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

  NCT05092360· 3. fázis· Mural Oncology Inc.· Forrás

• Lezárult

  A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

  NCT05651711· 3. fázis· Amgen· Forrás

• Leállították

  A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

  NCT05529316· 2. fázis· Agenus Inc.· Forrás

Showing 50 of 109.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Pitvarfibrilláció72 munka · 4 vizsgálat
• Parkinson-kór69 munka · 4 vizsgálat
• Atópiás dermatitisz (ekcéma)55 munka · 23 vizsgálat
• Pikkelysömör45 munka · 13 vizsgálat
• Melanóma41 munka · 21 vizsgálat
• Crohn-betegség38 munka · 25 vizsgálat
• Colitis ulcerosa37 munka · 29 vizsgálat
• Akut limfoid leukémia (ALL)36 munka · 16 vizsgálat
• Akut mieloid leukémia (AML)32 munka · 13 vizsgálat
• Ventricular tachycardia31 munka · 1 vizsgálat
• Mielóma multiplex24 munka · 11 vizsgálat
• Dystonia16 munka · 0 vizsgálat
• Hodgkin-limfóma15 munka · 3 vizsgálat
• Congenital heart disease15 munka · 0 vizsgálat
• Aortic stenosis14 munka · 9 vizsgálat
• Bronchiectasis14 munka · 3 vizsgálat
• Brain aneurysm11 munka · 1 vizsgálat
• Aortic aneurysm10 munka · 1 vizsgálat
• Köpenysejtes limfóma9 munka · 5 vizsgálat
• Essential tremor9 munka · 1 vizsgálat
• Epidermolysis bullosa6 munka · 0 vizsgálat
• Vitiligo6 munka · 3 vizsgálat
• Chronic spontaneous urticaria5 munka · 5 vizsgálat
• Giant cell arteritis4 munka · 1 vizsgálat
• Uterine fibroids4 munka · 0 vizsgálat
• Multiple system atrophy3 munka · 0 vizsgálat